ClinVar Miner

Submissions for variant NM_032043.3(BRIP1):c.1103C>G (p.Pro368Arg)

dbSNP: rs1064793072
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000486758 SCV000564811 uncertain significance not provided 2014-10-17 criteria provided, single submitter clinical testing This variant is denoted BRIP1 c.1103C>G at the cDNA level, p.Pro368Arg (P368R) at the protein level, and results in the change of a Proline to an Arginine (CCC>CGC). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. BRIP1 Pro368Arg was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Since Proline and Arginine differ in polarity, charge, size or other properties, this is considered a non-conservative amino acid substitution. BRIP1 Pro368Arg occurs at a position that is conserved across species and is located within the Helicase ATP-binding domain (UniProt). In silico analyses predict that this variant is probably damaging to protein structure and function. Based on currently available information, it is unclear whether BRIP1 Pro368Arg is pathogenic or benign. We consider it to be a variant of uncertain significance.
Ambry Genetics RCV002436525 SCV002745110 uncertain significance Hereditary cancer-predisposing syndrome 2019-04-01 criteria provided, single submitter clinical testing The p.P368R variant (also known as c.1103C>G), located in coding exon 7 of the BRIP1 gene, results from a C to G substitution at nucleotide position 1103. The proline at codon 368 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.